Latest filing published 17 Jan 2024 for P3 Health Partners Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Amir Bacchus: trading record in brief
Amir Bacchus (senior executive) discloses dealings in P3 Health Partners Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 3 December 2021 to 9 January 2024.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 January 2024 came the latest disclosure, a transaction in P3 Health Partners Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amir Bacchus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 287,118 sharesClass A Common StockSEC:0001628280-24-001542:0
- 287,118 shares@ US$1.41100.0% of flowClass A Common StockSEC:0001628280-24-000269:0
- 1,000,000 shares0Class A Common StockSEC:0001104659-23-088999:0
- 1,005,193 sharesClass A Common StockSEC:0001104659-23-043700:0
- 15,032,528 shares@ €1,329.579550.0% of flowClass V Common StockSEC:0001104659-21-147361:0
5 of 5 declarations